Tag Archives: view

hVIVO raises 2023 revenue view on demand for respiratory therapy testings

(Reuters) -hVIVO plc on Tuesday raised its 2023 income forecast after the healthcare firm reported a 52% bounce in gross sales within the first half as demand for testing of infectious and respiratory illness therapies elevated. Drugmakers are in a race to develop vaccines and medicines to deal with respiratory illnesses brought on by respiratory syncytial virus and COVID-19, leading …

Read More »